Results 121 to 130 of about 227,630 (203)

Ketogenic Nutrition in Combination With PPARα Activation Induced Metabolic Failure and Exacerbated Muscle Weakness in Septic Mice. [PDF]

J Cachexia Sarcopenia Muscle
Lauwers C, Vankrunkelsven W, Derde S, Vander Perre S, Derese I, Pauwels L, Vanhorebeek I, Libbrecht L, Vermeersch P, Gunst J, Van den Berghe G, Casaer MP, Langouche L.   +12 more
europepmc   +1 more source

HSA^LR Mice Exhibit Co-Expression of Proteostasis Genes Prior to Development of Muscle Weakness. [PDF]

Int J Mol Sci
Lazic DM, Jovanovic VM, Karanovic J, Savic-Pavicevic D, Jovanovic B.   +4 more
europepmc   +1 more source

Biallelic <i>CRELD1</i> variants cause severe muscle weakness and infantile epilepsy. [PDF]

Brain Commun
D'Alessandro M, Bamborschke D, Bülow MH, Özdemir Ö, Daimagüler HS, Brümmer V, Kucharowski N, Sellin J, Brunn A, Deckert M, Wunderlich G, Koerber F, Bessereau JL, Cirak S.   +13 more
europepmc   +1 more source

Elevated Levels of Active GSK3β in the Blood of Patients with Myotonic Dystrophy Type 1 Correlate with Muscle Weakness. [PDF]

Int J Mol Sci
Jennings K, Tian C, Brown RL, Horn PS, Schoser B, Kushlaf H, Timchenko NA, Timchenko L.   +7 more
europepmc   +1 more source

Impact of rAAV-shRNA treatment targeting mechanosensitive Ilk1 and Fermt2 in a mouse model of sepsis-induced muscle weakness. [PDF]

PLoS One
Pacolet A, Derese I, Pauwels L, Perre SV, Smits M, Van den Haute C, Derde S, Koppo K, Gijsbers R, Langouche L.   +9 more
europepmc   +1 more source

Structural basis for simvastatin-induced skeletal muscle weakness associated with type 1 ryanodine receptor T4709M mutation. [PDF]

J Clin Invest
Weninger G, Dridi H, Reiken S, Yuan Q, Zhao N, Groom L, Leigh J, Liu Y, Tchagou C, Kang J, Chang A, Luna-Figueroa E, Miotto MC, Wronska A, Dirksen RT, Marks AR.   +15 more
europepmc   +1 more source

Association Between Bottle-Opening Ability and Muscle Weakness in Patients With Coronary Artery Disease. [PDF]

Circ Rep
Ishihara K, Izawa KP, Kitamura M, Ogawa M, Kanejima Y, Naito Y, Morisawa T, Shimizu I.   +7 more
europepmc   +1 more source

Due to Limitations in the Feasibility of the Perme Score, it should not be Used to Classify Muscle Weakness in Intensive Care Unit Patients. [PDF]

Indian J Crit Care Med
Zarrouk S, Finsterer J.
europepmc   +1 more source

Muscle weakness after critical illness: unravelling biological mechanisms and clinical hurdles. [PDF]

Crit Care
Pierre A, Favory R, Bourel C, Howsam M, Romien R, Lancel S, Preau S.   +6 more
europepmc   +1 more source